USP Still Has a Long Way to Go in Updating Excipient Monographs
This article was originally published in The Gold Sheet
Executive Summary
U.S. Pharmacopeia officials say they have only modernized about 10% of the excipient monographs deemed a high priority in need of modernization by FDA and have received “minimal” input from industry in updating outdated monographs.